4
Changes in Ownership
CYTOKINETICS INC Filed Acc 0001127602-25-009355
EVP, Chief Commercial Officer sold 26,771 shares at $43.62 ($1,167,751)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Callos Andrew · EVP, Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-13 | Sale : show line 1 in the form 10b5-1 | −26,771 | $43.62 | $1,167,751 | 37,663 | D |
| Open-market sales · 26,771 sh · avg $43.62 · $1,167,751 | ||||||
Loading xslF345X05/form4.xml…